On The BioCentury Show, Dr. Glimcher calls for funding basic research, and describes the struggles of academic medical centers
Watch as Dr. Glimcher also discusses increasing access to new and experimental cancer therapies to underserved minorities. [BioCentury, May 5, 2022]
Dr. Glimcher speaks with Bloomberg Radio about health care and cancer issues
Listen to Dr. Glimcher’s wide-ranging talk with Bloomberg Radio on issues like clinical trials, drug prices, and the current state of cancer research. [Bloomberg Radio, April 8, 2022; interview starts at 26:16]
Dr. Glimcher Honored by Forbes as a 2021 Forbes Healthcare Summit Top 10 Leader of the Decade
Congratulations to Laurie Glimcher, MD, Dana-Farber President and CEO. Watch her interview with Forbes. [Forbes Media, December 10, 2021]
The Importance of Vaccinating Cancer Patients Against COVID-19
Dr. Glimcher discusses the importance of ensuring vaccinations for this particularly vulnerable group of patients. [WGBH/GBH News, January 26, 2021]
Managing through a crisis
Dr. Glimcher offers her lesson from a turbulent year. [Boston Globe, November
Becker's Healthcare Podcast: Equity in cancer care, and more
Dr. Glimcher discusses the efforts being made for equity in cancer care, the rapid improvements being made in oncology in the past few years, and more. [Becker's Healthcare Podcast, November 2, 2020].
Message from Dr. Glimcher to staff about the kind of community we want Dana-Farber to be
Letter to all Dana-Farber staff in response to the U.S. Supreme Court ruling that a landmark civil rights law protects the employment of LGBTQ+ workers. [June 16, 2020]
President's Statement on World Cancer Day 2020
Read Dr. Glimcher's powerful statement, "World Cancer Day 2020: Beginning of the End of Cancer."
Boston Globe: "2019 Top 100 Women-Led Businesses in Massachusetts"
View Dr. Glimcher's place in the top 10. [Boston Globe,
November 8, 2019]
Interview with S&P Global Intelligence: "Collaboration Is Essential for Next Cancer Breakthrough"
Dr. Glimcher offers descriptions of, and insights about, the Institute's ongoing work; the challenges of running successful cancer programs; and the future of cancer treatment. [S&P Global Intelligence, September 26, 2019]
Op-Ed in the Boston Globe: "Ending the Long Reach of Tobacco"
As a physician-scientist and president of an academic medical center dedicated to reducing the burden of cancer, Dr. Glimcher sees the tragic results of tobacco use every day. She offers an urgent call to reduce tobacco use, especially among the young, to help safeguard future generations from addiction, disease, and loss of life. [June 13, 2019]
Interview with Forbes Magazine: "Where's the Push for More Innovation?"
With Dana-Farber's leadership in basic cancer research as background, Dr. Glimcher offers insights on reforming and transforming American health care. [Forbes, May 19, 2019]
Participation in Bloomberg Baystate Business/Boston College Chief Executives Club Luncheon
Hear Dr. Glimcher's insights on Dana-Farber research and care; she is the first interviewee on this special edition of
Bloomberg Baystate Business
, recorded live at the Boston College Chief Executives Club Luncheon. [April 12, 2019]
Rare Cancers: Charting a Faster Route to Treatment
Dr. Glimcher and other panelists discuss how advances in cancer immunology, innovative trial designs, and international data-sharing can create new hope for patients with rare cancers. [Harvard T.H. Chan School of Public Health/The Economist Group, February 1, 2019]
Participation in U.S. News's "Healthcare of Tomorrow" conference on improving health and cutting costs
Beginning at 1:28:30, view Dr. Glimcher's insightful remarks about the ways that immunology and other breakthroughs are transforming cancer care [November 14, 2018]
Participation in panel discussion, "Leading on Value — Solutions for an Evolving Health Care System"
View Dr. Glimcher's participation in this timely and important topic. [The Economist and Roll Call, October 2018]
Q & A with Dr. Glimcher as she discusses issues facing academic medical centers and the joys of being a physician-scientist
Read Dr. Glimcher's thoughts and ideas on the state of cancer medical research and clinical care, as well as some of her personal
reflections. [Becker's Hospital Review, June 7, 2018]
Participation in Davos World Economic Forum panel, "The New Health Paradigm"
View Dr. Glimcher's participation in a health care forum at Davos discussing a new archetype called the “value” or “outcomes-based” paradigm. [January 23,
"The NIH is in danger of losing its edge in creating biomedical innovations"
Read Dr. Glimcher's co-authored STAT article, calling for a renewed commitment to federal funding for biomedical research; offering ideas to reform and bolster the NIH; and recommending new steps to integrate public and private research. [STAT,
January 1, 2018]
On Receiving the AAMC Award for Distinguished Research in the Biomedical Sciences
View Dr. Glimcher's insights on receiving the Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges (AAMC). [November
State-of-the-Institute Address to Visiting Committee
View Dr. Glimcher's update on the excellent progress in research and care initiatives at Dana-Farber. [November
Appearance at The Atlantic's "Through the Microscope" Forum
Watch Dr. Glimcher explore "The DNA of Modern Medicine" with The Atlantic's Joie Chen. [February 21, 2017]
Dr. Glimcher in the News
Dr. Glimcher named to Modern Healthcare's 2018 list of 100 most influential people in healthcare [August 2018]
Dr. Glimcher named to Modern Healthcare's 2018 list of 50 most influential physician executives and leaders [June 18, 2018]
Laurie H. Glimcher, MD, receives 2018 American Association of Immunologists (AAI) Lifetime Achievement Award [May
Former Dana-Farber researcher Laurie Glimcher returns to run storied institution [Boston Business Journal, May 25, 2017]
Dana-Farber's New President Talks Health Care Costs, Disease Treatments, and Research Competition [WGBH Morning Edition, Part 1,
May 24, 2017]
Dana-Farber's New President Addresses Innovation, Obamacare, and Women in Science [WGBH Morning Edition, Part 2,
May 25, 2017]
New Head of Dana-Farber on AHCA, Boston Roots and Women in Science [WBUR Radio Boston, March 15, 2017]
Op Ed on FDA Regulations [Boston Globe, May 4, 2017]
Five things you should know about Laurie Glimcher [Boston Globe,
April 28, 2017]
Dr. Glimcher honored with 2017 Kober Medal from the Association of American Physicians [AAP]
Dr. Glimcher’s remarks to the Greater Boston Chamber of Commerce – April 7, 2017 [Boston Chamber of Commerce]
With Trump's proposed NIH cuts, Mass. has more to lose than any other state [Boston Business Journal, March
Cancer Moonshot [WGBH-TV, December 14, 2016]
Here's what the CEO of Dana-Farber had to say after the signing of 21st Century Cures Act [Boston Business Journal,
December 13, 2016]
Incoming Dana-Farber President on the State of Cancer Research [WBUR-FM, September 12, 2016]
New Dana-Farber CEO on why this is the most exciting time for cancer treatment [Boston Business Journal,
February 24, 2016]
Scientists hope Trump won't decrease the flow of federal research dollars [Boston Globe,
November 20, 2016]
Boston's potential, the future of medicine and Donald Trump [Boston Business Journal, October 27, 2016]
Leading Physician-Scientist Laurie H. Glimcher to Receive 2016 Marion Spencer Fay Award at Drexel [Drexel Now. September 1, 2016]
Dana-Farber recruits Cornell medical dean as CEO [Boston Globe, February 23, 2016]
Dr. Laurie Glimcher on Putting Everything on the Line [New York Times, October 25, 2015]
New Head of Dana-Farber on AHCA, Boston Roots and Women in Science [WBUR-FM, March 15, 2017]
View Dr. Glimcher's scientific publications.